Литература. 
Нежелательные лекарственные реакции и взаимодействия при антибиотикотерапии инфекций мочевыводящих путей

лекарственный антибактериальный терапия аллергический.

• 1. White T.J. Cjunting the Cost of Drug-Related Adverse Events. Pharmacoeconomics 1999; 445−58.
• 2. Lazarou J., Pomeranz B., Corey P. Incidence of Adverse Drug Reaction in Hospitalized Patients: A Meta-analysis of Prospective Studies. JAMA 1998; 279: 1200−5.
• 3. Garcia Rodrigues L.A., Stricker B.H., Zimmerman H.J. Risk of acute liver injury associated with the combination of amoxicillin and clavulanic acid. Arch Intern Med 1996; 156: 1327−32.
• 4. Limauro D.L., Chan-Tompkins N.H., Carter R.W. et al. Amoxicillin/clavulanate-associated hepatic failure with progression to Stevens-Johnson syndrome. Ann Intern Med 1996; 156: 1327−32.
• 5. Neu H.C., Wilson A.P.R., Gruneberg R.N. et al. Amoxicillin/Clavulanic Acid: a Review of its Efficacy in over 38,500 Patients from 1979 to 1992. J Chemother 1993; 5: 67−93.
• 6. Thompson J.W., Jacobs R.F. Adverse effects of newer caphalosporins. An update. Drug Saf 1993; 9: 132−42.
• 7. Norrby S.R. Side Effects of Cephalosporins. Drugs 1995; 34 (Suppl. 2): 105−20.
• 8. Karchmet A.W. In: Principles and Practice of Infectious Diseases / Ed. by G.L. Mandel. J.E. Bennerr. R.Dolin. — 5th ed. Philadelphia, 2000; 275−91.
• 9. Hoitsma A.J., Wetzels J.F., koene R.A. Drug-induced nephrorozicity. Aetiology, clinical features and management. Druh Saf 1991; 6: 131−47.
• 10. McCarty J.M., Richard G., Huck W. et al. A randomized trial of short-course ciprofloxacin, ofloxacin or trimethoprim/sulfamethpxazole for the treatment pf acute urinary tract infection in women. Am J Med. 1999; 106: 292−9.
• 11. Naldi L., Comforti A., Venegomi M. et al. Cutaneous reactions to drugs. An analysis of opontaneous reports in four Italian regions. Br J Clin Pharmacol 1991; 48: 839−46.
• 12. Mockenhaupt M., Schopf E. Progress in Allergy and Clinical Immunology, vol. 4, Cancun (Mexico): proceedings of the XVIth International Congress of Allergology and Clinical Immunology, Cancun, Mexico, 1997; 352−8.
• 13. Mahboob A., Haroon T.S., Drugs causing fixed erutrions: a study of 450 cases. Int J Detmatol 1998; 37: 833−8.
• 14. Van der Klaum M.M., Wilson J.H., Stricker B.H. Drug-associated anaphylaxis: 20 year of reporting in the Netherlands (1974;1994) and review of the literature. Clin Exp Allergy 1996; 26: 1355−63.
• 15. Pedersen-Bjergaard U., Andersen M., Hansen P.B. Thrombocytopenia induced by noncytotoxic drugs in Denmark 1968;91. J Intern Med 1996; 239: 509−15.
• 16. Miagawa S., Yamasina Y., Hirota S., Shirai T. Fixed drug eruption due to piemidic acid. J Dermatol 1991; 18: 59−60.
• 17. Harrell R.M. Fluorowuinolone-Induced Tendinopathy: Whan Do We Know? South Med J 1999; 92: 622−5.
• 18. Lipsky B.A., Baker C.A. Fluorowuinolone Toxicity Profiles: A Review Focusing on Newer Agents. Clin Infect Dis 1999; 28: 352−64.
• 19. Henry D.C., Nenad R.C., Iravani A. et al. Comparison of sparfloxacin and ciprofloxacin in the treatment of community-acquuired acute uncomplicated urinary tract infection in women. Sparfloxacin Multicenter Uncomplicated Urinary Tract Infection Study Grout. Clin Ther 1999; 21: 966−81.
• 20. Bottiger L.E., Westerholm B. Adverse drug reactions during treatment of urinary tract infections. Eur J Clin Phatmacol 1997; 11: 439−42.
• 21. Hallas J., Gram L.F., Grodum E., Damsbo N., Brosen K., Haghfelt T. et al. Drug related admissions to medical wards: a population based survey. Br J Clin Pharmacol 1992; 33: 61−8.
• 22. Jick S.S., Jick H., Walker A.M., Hunter J.R. Hospiralizations for pulmonfry reactions following nitrofurantion use. Chest 1989; 96: 512−5.
• 23. Hooper D.C., In G.L. Mandell, J.E. Bennett and R. Dolin (eds.). New York: Churchill Livingstone. 1995; 376−81.
• 24. Gait J.E. Hemolytic reactions to nitrofunantoin in patients with glucose-6-phosphate dehydrogenase deficiency: theory and practice. DICP 1990; 24: 1210−3.
• 25. Zielonka T.M., Demkow U., Kus J. Pulmonary reaction after furazidin (Furagin). Case report. Pol Ah Med Wewn. 1997; 97: 465−72.
• 26. Crocchiolo P. Single-Dose Fosfonycin Trometamol verses Multiple-Dose Cotrimaxazole in the Treatment of Lower Urinary Tract Infections in General Pracrice. Chemotherapy. 1990; 36: 37−40.
• 27. Patel S.S., Balfour J.A., Bryson H.M. Fosfomycin Tromethamine. Drags. 1997; 53: 637−56.
• 28. Blindness and neuropathy from diiodihudroxyquin-like drugs. Committee on drugs. Pediatrics. 1974; 54: 378−9.
• 29. Hutzeler D., Pevny I. Allergies to 8-hydroxyquinoline derivatives. Derm Beruf Umwelt. 1988; 36:86−90.
• 30. Rose F.C., Gawel M. Clioquinol neurotoxicity: An overview. Acta Neurol Scand. 1978; 70 (Suppl. 100): 137−45.